Terms: = Liver cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Staging
88 results:
1. Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after liver Resection.
Jiang H; Yang C; Chen Y; Wang Y; Wu Y; Chen W; Ronot M; Chernyak V; Fowler KJ; Bashir MR; Song B
Radiology; 2023 Nov; 309(2):e230527. PubMed ID: 37934100
[TBL] [Abstract] [Full Text] [Related]
2. Ovarian Mesonephric-Like Adenocarcinoma With Recurrent liver Metastases: A Case Report with Analysis of Therapeutic Molecular Targets.
Sugitani A; Ogawa A; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2024 May; 32(3):578-585. PubMed ID: 37345348
[TBL] [Abstract] [Full Text] [Related]
3. CS-iCCA, A New Clinically Based staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation.
Lozada ME; Zhang N; Jin W; Wongjarupong N; Yang JD; Voss MM; Prasai K; Amakye DO; Harmsen WS; Chaudhary S; Bathe OF; Borad MJ; Patel TC; Gores GJ; Therneau TM; Roberts LR
Am J Gastroenterol; 2023 Dec; 118(12):2173-2183. PubMed ID: 36940423
[TBL] [Abstract] [Full Text] [Related]
4. Impact of 68 Ga-FAPI-04 PET/CT on staging and Therapeutic Management in Patients With Digestive System Tumors.
Kosmala A; Serfling SE; Schlötelburg W; Lindner T; Michalski K; Schirbel A; Higuchi T; Hartrampf PE; Buck AK; Weich A; Werner RA
Clin Nucl Med; 2023 Jan; 48(1):35-42. PubMed ID: 36354691
[TBL] [Abstract] [Full Text] [Related]
5. Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of abdominal radiology disease focus panel on PDAC.
Chu LC; Wang ZJ; Kambadakone A; Hecht EM; He J; Narang AK; Laheru DA; Arif-Tiwari H; Bhosale P; Bolan CW; Brook OR; Bezuidenhout AF; Do RKG; Galgano SJ; Goenka AH; Guimaraes AR; Hough DM; Kulkarni N; Le O; Luk L; Mannelli L; Rosenthal M; Sangster G; Shah ZK; Soloff EV; Tolat PP; Zins M; Fishman EK; Tamm EP; Zaheer A
Abdom Radiol (NY); 2023 Jan; 48(1):318-339. PubMed ID: 36241752
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry.
Metzenmacher M; Griesinger F; Hummel HD; Elender C; Schäfer H; de Wit M; Kaiser U; Kern J; Jänicke M; Spring L; Zacharias S; Kaiser-Osterhues A; Groth A; Hipper A; Zaun G; Dörfel S; Güldenzoph B; Müller L; Uhlig J; Thomas M; Sebastian M; Eberhardt WEE;
Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36180086
[TBL] [Abstract] [Full Text] [Related]
7. Natural Language Processing of Computed Tomography Reports to Label Metastatic Phenotypes With Prognostic Significance in Patients With Colorectal cancer.
Causa Andrieu P; Golia Pernicka JS; Yaeger R; Lupton K; Batch K; Zulkernine F; Simpson AL; Taya M; Gazit L; Nguyen H; Nicholas K; Gangai N; Sevilimedu V; Dickinson S; Paroder V; Bates DDB; Do R
JCO Clin Cancer Inform; 2022 Sep; 6():e2200014. PubMed ID: 36103642
[TBL] [Abstract] [Full Text] [Related]
8. FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision-making in real-world.
Marschner N; Hegewisch-Becker S; Reiser M; von der Heyde E; Bertram M; Hollerbach SH; Kreher S; Wolf T; Binninger A; Chiabudini M; Kaiser-Osterhues A; Jänicke M;
Int J Cancer; 2023 Feb; 152(3):458-469. PubMed ID: 36053905
[TBL] [Abstract] [Full Text] [Related]
9. Optimization of the BCLC staging System for Locoregional Therapy for Hepatocellular Carcinoma by Using Quantitative Tumor Burden Imaging Biomarkers at MRI.
Borde T; Nezami N; Laage Gaupp F; Savic LJ; Taddei T; Jaffe A; Strazzabosco M; Lin M; Duran R; Georgiades C; Hong K; Chapiro J
Radiology; 2022 Jul; 304(1):228-237. PubMed ID: 35412368
[TBL] [Abstract] [Full Text] [Related]
10. OLGA- and OLGIM-Based staging in the Patients with Gastritis and Endoscopy Indications.
Mansour-Ghanaei F; Joukar F; Yeganeh S; Sadeghi M; Daryakar A; Sepehrimanesh M
Turk J Gastroenterol; 2022 Feb; 33(2):95-102. PubMed ID: 35238779
[TBL] [Abstract] [Full Text] [Related]
11. UNOS Down-staging Criteria for liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies.
Tan DJH; Lim WH; Yong JN; Ng CH; Muthiah MD; Tan EX; Xiao J; Lim SY; Pin Tang AS; Pan XH; Kabir T; Bonney GK; Sundar R; Syn N; Kim BK; Dan YY; Noureddin M; Loomba R; Huang DQ
Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1475-1484. PubMed ID: 35181565
[TBL] [Abstract] [Full Text] [Related]
12. Single-Center Comparison of [
Mirzaei S; Lipp R; Zandieh S; Leisser A
Curr Oncol; 2021 Oct; 28(5):4167-4173. PubMed ID: 34677271
[TBL] [Abstract] [Full Text] [Related]
13. Adjuvant therapy in patients with sarcomatoid renal cell carcinoma: post hoc analysis from Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) E2805.
Karam JA; Puligandla M; Flaherty KT; Uzzo RG; Matin SF; Pins MR; Wood CG; Kane C; Jewett MAS; Kim SE; Dutcher JP; DiPaola RS; Haas NB
BJU Int; 2022 Jun; 129(6):718-722. PubMed ID: 34480522
[TBL] [Abstract] [Full Text] [Related]
14. Pan-cancer analysis of prognostic metastatic phenotypes.
Zaorsky NG; Wang X; Garrett SM; Lehrer EJ; Lin C; DeGraff DJ; Spratt DE; Trifiletti DM; Kishan AU; Showalter TN; Park HS; Yang JT; Chinchilli VM; Wang M
Int J Cancer; 2022 Jan; 150(1):132-141. PubMed ID: 34287840
[TBL] [Abstract] [Full Text] [Related]
15. Identifying enhancement-based staging markers on baseline MRI in patients with colorectal cancer liver metastases undergoing intra-arterial tumor therapy.
Ghani MA; Fereydooni A; Chen E; Letzen B; Laage-Gaupp F; Nezami N; Deng Y; Gan G; Thakur V; Lin M; Papademetris X; Schernthaner RE; Huber S; Chapiro J; Hong K; Georgiades C
Eur Radiol; 2021 Dec; 31(12):8858-8867. PubMed ID: 34061209
[TBL] [Abstract] [Full Text] [Related]
16. cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty liver Disease: A Population-Based Cohort Study.
Simon TG; Roelstraete B; Sharma R; Khalili H; Hagström H; Ludvigsson JF
Hepatology; 2021 Nov; 74(5):2410-2423. PubMed ID: 33811766
[TBL] [Abstract] [Full Text] [Related]
17. Hepatic Arterial Infusion Chemotherapy with Modified FOLFOX as an Alternative Treatment Option in Advanced Hepatocellular Carcinoma Patients with Failed or Unsuitability for Transarterial Chemoembolization.
Hsu SJ; Xu X; Chen MP; Zhao ZY; Wang Y; Yin X; Zhang L; Ge NL; Chen Y; Wang YH; Luo JF; Ren ZG; Chen RX
Acad Radiol; 2021 Nov; 28 Suppl 1():S157-S166. PubMed ID: 33653656
[TBL] [Abstract] [Full Text] [Related]
18. Comparison of
Pang Y; Zhao L; Luo Z; Hao B; Wu H; Lin Q; Sun L; Chen H
Radiology; 2021 Feb; 298(2):393-402. PubMed ID: 33258746
[TBL] [Abstract] [Full Text] [Related]
19. Risk Score Model for liver Transplant Outcomes after Preoperative Locoregional Therapy for Hepatocellular Carcinoma.
Bhatti ABH; Hassan M; Rana A; Khan NY; Khan ZA; Zia HH
J Gastrointest Cancer; 2022 Mar; 53(1):84-90. PubMed ID: 33184772
[TBL] [Abstract] [Full Text] [Related]
20. Integrating baseline MR imaging biomarkers into BCLC and CLIP improves overall survival prediction of patients with hepatocellular carcinoma (HCC).
Aliyari Ghasabeh M; Shaghaghi M; Pandey A; Ameli S; Ambale Venkatesh B; Jacob A; Pandey P; Hazhirkarzar B; Luo Y; Rezvani Habibabadi R; Khoshpouri P; Ghadimi M; Kamel IR
Eur Radiol; 2021 Mar; 31(3):1630-1641. PubMed ID: 32910233
[TBL] [Abstract] [Full Text] [Related]
[Next]
